North America Paper Packaging Market - Growth, Trends, and Forecast (2020 - 2025)

The North America Paper Packaging Market can be segmented by End-user Vertical (Pharmaceutical, Medical Devices), Product Type (Bottles and Containers, Vials and Ampoules, Cartridges and Syringes, Pouch and Bags, Blister Packs, Tubes, Paper Board Boxes, Caps and Closures, Labels, and Other Product Types), Material (Glass, Plastic, and Other Materials), and Country(the United States and Canada).

Market Snapshot

Study Period:

2019-2025

Base Year:

2019

CAGR:

6.37 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The North American healthcare packaging market was valued at USD 45.3 billion in 2019, and it is expected to reach USD 65.6 billion by 2025, registering a CAGR of 6.37%, during the period of 2020-2025.

  • The healthcare industry has widely evolved from its traditional form of practices to its current position, where the high-tech equipment and instruments are deployed to improve efficiency, in addition to the increasing demand for sustainable packaging and processing operations.
  • The increasing awareness on the environmental issues and the government regulations of the region are pressurizing the pharmaceutical companies in moving toward sustainable processes. These developments by medical devices and pharmaceutical vendors are catering to provide scope toward the expansion of the healthcare packaging market.
  • Multiple studies have proven improved adherence and health outcomes with a combination of multimed blister packs and medication therapy management (MTM). A study conducted by Omnicell suggested that patients assigned to the multimed packaging groups accounted for medication adherence rates of 80%, whereas 90% adherence rates by the completion of the trial in the country. Alternatively, patients assigned to the pill bottle-only group accounted for an adherence rate of 56%.​​
  • The increasing need for anti-counterfeiting techniques, to protect the interests of patients, has further strengthened the growth of the healthcare packaging. The introduction of regulations known as the Anti-counterfeiting Trade Agreement by the United States and the labeling is expected to positively impact the market in the region over the forecast period.
  • New companies are innovating in terms of the economical ways and smart labeling of medical devices. For instance, CleanCut Technologies' Vault packaging system for devices is well suited for tray-style packaging. Counterfeiting, an evident problem in medical devices, is expected to promote the usage of NFC and RFID tags on the packaging materials.

Scope of the report

The healthcare industry has evolved from its traditional form of practices to the current position, where high-tech equipment and instruments are being deployed to improve efficiency and cater to the increasing demand for sustainable packaging and processing operations. The market is segmented by End-user, Product Type, Material, and Country.

By End-user Vertical
Pharmaceutical
Medical Devices
By Product Type
Bottles and Containers
Vials and Ampoules
Cartridges and Syringes
Pouch and Bags
Blister Packs
Tubes
Paper Board Boxes
Caps and Closures
Labels
Other Product Types (Trays, Aerosol Cans, and Clamshells)
By Material
Glass
Plastic
Other Materials (Paper and Metal)
By Country
United States
Canada

Report scope can be customized per your requirements. Click here.

Key Market Trends

Increased Emphasis on Convenience and Environmental Issues

  • Over the decades, there has been growing awareness toward environmental hazards that are related to the disposal and recycling of packaging, with numerous government initiatives and increasingly stringent regulations.
  • In the US, several organizations are calling for more environmental products. In recent past years, four major healthcare companies and two NGOs launched the Greenhealth Exchange, an organization that will investigate and promote green alternatives. When it comes to clinical supplies, players want to start with products used in the Neonatal and Pediatric ICUs, as the youngest patients are the most vulnerable to having health effects from some of the (such as toxic) chemicals that can be found in plastic products like IV tubing.
  • The pharmaceutical industry in Canada is transforming itself to respond to new realities. According to the OECD, pharmaceutical spending per capita in Canada stood at around USD 832, as of 2018. According to Thomson Reuters, Canada established itself as the fourth-largest market for life sciences’ mergers and acquisitions, with 118 deals in 2019.​ Consumption of medicines is increasing due to the rising incidences of chronic diseases, leading to the accumulation of non-biodegradable packaging waste. For reducing such waste, it is vital to use biodegradable packaging materials that do not harm nature.​
  • Seeking to capture such demands, key major players are focused on the technological advancements and development of various innovative biodegradable packaging materials, which may boost the market. ​For instance, Gerresheimer AG showcased its eco-friendly packaging products, which include containers with green packaging, a plastic container made of sugarcane, Duma Combi, a tablet packaging container with a separate compartment for the patient information leaflet, and others.​

To understand key trends, Download Sample Report

Rise In Medicine Counterfeiting Leading to Advanced Packaging and Labeling

  • Counterfeit drugs are increasingly infiltrating the pharmaceutical supply chain, threatening the health of patients and incurring a high cost to drug manufacturers. Around 19 million Americans purchase the medication outside of the secure supply chain, mostly from approximately 50,000 global online pharmacies. A comprehensive study of 11,700 online pharmacies accessible to US customers found that approximately 95% failed to fully comply with laws and industry standards to protect patients.
  • The US Food and Drug Administration (FDA) enforces rule 21 CFR Part 2112, which specifies current good manufacturing practice for finished pharmaceuticals. Within this framework, the rule mandates that tamper-evident packaging should be used for over-the-counter (OTC) human drug products. According to the regulation, a tamper-evident package has one or more indicators or barriers to entry, which, if breached or missing, can reasonably be expected to provide visible evidence that tampering has occurred. It should not be able to duplicate the packaging using commonly available materials or processes.
  • Many producers and distributors are primarily seeking to gain greater visibility over their supply chain operations in order to deter counterfeiting. RFID and NFC enabled packaging can monitor the movement in real-time, which allows for quick alerts when a shipment gets diverted or tampered with. Thus, manufacturers, distributors, and even minor supply chain partners can be assured that they are dealing with authentic products that can be readily verified at any time. Such product verification and tracking capabilities will aid manufacturers in achieving aggressive serialization and aggregation goals set out by the DSCSA (Drug Supply Chain Security Act).

To understand geography trends, Download Sample Report.

Competitive Landscape

The market comprises of prominent players such as Corning Incorporated, Schott AG, Gerresheimer AG, and Nipro Corporation. The market is depictive of stringent packaging compliance and maintenance of high-quality packaging material production and presence of prominent players directly affects the barriers to entry. Some of the recent developments in the market include:

April 2020: Gerresheimer Group and Centor Inc. laid the foundations for a new warehouse covering 72,000 square feet. The new storage facility is being built right next to the existing one on Centor’s site in Berlin, Ohio (United States). This new warehouse will enable Centor to store all of its products on site, reducing the need for external storage.

May 2020: Corning Incorporated and Pfizer Inc. announced the execution of a long-term purchase and supply agreement for Corning Valor Glass. The multiyear agreement provides for the supply of Valor Glass vials to a portion of currently marketed Pfizer drug products, pending regulatory approval.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET INSIGHTS

    1. 4.1 Market Overview

    2. 4.2 Assessment of the COVID-19 Impact

    3. 4.3 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.3.1 Bargaining Power of Suppliers

      2. 4.3.2 Bargaining Power of Consumers

      3. 4.3.3 Threat of New Entrants

      4. 4.3.4 Threat of Substitutes

      5. 4.3.5 Intensity of Competitive Rivalry

    4. 4.4 Industry Value Chain Analysis

  5. 5. MARKET DYNAMICS

    1. 5.1 Market Drivers

      1. 5.1.1 Increased Emphasis on Convenience and Environmental Issues

      2. 5.1.2 Rise in Medicine Counterfeiting Leading to Advanced Packaging and Labeling

    2. 5.2 Market Restraints

      1. 5.2.1 Environmental Concerns Related to Raw Materials for Packaging and Price Competition

  6. 6. MARKET SEGMENTATION

    1. 6.1 By End-user Vertical

      1. 6.1.1 Pharmaceutical

      2. 6.1.2 Medical Devices

    2. 6.2 By Product Type

      1. 6.2.1 Bottles and Containers

      2. 6.2.2 Vials and Ampoules

      3. 6.2.3 Cartridges and Syringes

      4. 6.2.4 Pouch and Bags

      5. 6.2.5 Blister Packs

      6. 6.2.6 Tubes

      7. 6.2.7 Paper Board Boxes

      8. 6.2.8 Caps and Closures

      9. 6.2.9 Labels

      10. 6.2.10 Other Product Types (Trays, Aerosol Cans, and Clamshells)

    3. 6.3 By Material

      1. 6.3.1 Glass

      2. 6.3.2 Plastic

      3. 6.3.3 Other Materials (Paper and Metal)

    4. 6.4 By Country

      1. 6.4.1 United States

      2. 6.4.2 Canada

  7. 7. COMPETITIVE INTELLIGENCE – COMPANY PROFILES

    1. 7.1 Gerresheimer AG

    2. 7.2 Corning Incorporated

    3. 7.3 Nipro Corporation

    4. 7.4 SGD SA (SGD Pharma)

    5. 7.5 Stölzle-Oberglas GmbH (CAG Holding GmbH)

    6. 7.6 Bormioli Pharma AG

    7. 7.7 Schott AG

    8. 7.8 Shandong Pharmaceutical Glass Co. Ltd

    9. 7.9 Beatson Clark PLC

    10. 7.10 Arab Pharmaceutical Glass Co

    11. 7.11 Piramal Glass Pvt. Ltd

    12. 7.12 Şişecam Group

  8. 8. INVESTMENT ANALYSIS

  9. 9. FUTURE OUTLOOK OF THE MARKET

** Subject to Availability

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports